Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer

Adrenocortical carcinoma (ACC) is a rare orphan disease with a dismal prognosis. Surgery remains the first-line treatment, but most patients eventually develop metastatic disease. Mitotane is often used with chemotherapy with modest success. Little information is available concerning the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Head, Lia, Kiseljak-Vassiliades, Katja, Clark, Toshimasa J, Somerset, Hilary, King, Jonathan, Raeburn, Christopher, Albuja-Cruz, Maria, Weyant, Michael, Cleveland, Joseph, Wierman, Margaret E, Leong, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853671/
https://www.ncbi.nlm.nih.gov/pubmed/31745526
http://dx.doi.org/10.1210/js.2019-00305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853671/
https://www.ncbi.nlm.nih.gov/pubmed/31745526
http://dx.doi.org/10.1210/js.2019-00305

Ejemplares similares